SCH-23390 hydrochloride is a potent and selective dopamine D1-like receptor antagonist, widely used as a pharmacological tool to study D1 and D5 dopamine receptor functions; it acts as an agonist at h5-HT2C receptors and directly inhibits G protein-coupled inwardly rectifying potassium (GIRK) channels; it has been employed in research on neurological disorders involving the dopamine system, such as psychosis and Parkinson’s disease; it abolishes generalized seizures induced by chemoconvulsants; it is extensively utilized for the topographical mapping of brain D1 receptors in rodents, nonhuman primates, and humans; and it enhances dopamine-induced ductus arteriosus constriction in CD-1 mouse vessels under newborn oxygen conditions.